Micafungin
Pre-clinicalCompleted 2 views this week 0 watching💤 Quiet
Interest: 26/100
26
Development Stage
1
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Invasive Fungal Infections
Conditions
Invasive Fungal Infections
Trial Timeline
Mar 1, 2015 → Aug 1, 2015
NCT ID
NCT02678598About Micafungin
Micafungin is a pre-clinical stage product being developed by Astellas Pharma for Invasive Fungal Infections. The current trial status is completed. This product is registered under clinical trial identifier NCT02678598. Target conditions include Invasive Fungal Infections.
What happened to similar drugs?
10 of 20 similar drugs in Invasive Fungal Infections were approved
Approved (10) Terminated (2) Active (9)
Hype Score Breakdown
Clinical
3
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (15)
| NCT ID | Phase | Status |
|---|---|---|
| NCT03174457 | Pre-clinical | Completed |
| NCT03102658 | Approved | Completed |
| NCT02440178 | Phase 2 | Completed |
| NCT03421002 | Phase 2 | Completed |
| NCT02678598 | Pre-clinical | Completed |
| NCT02127788 | Pre-clinical | Completed |
| NCT02646800 | Approved | Terminated |
| NCT02646774 | Approved | Terminated |
| NCT02057289 | Phase 1 | Terminated |
| NCT01982071 | Approved | Terminated |
| NCT01135589 | Approved | UNKNOWN |
| NCT00606268 | Phase 1 | Completed |
| NCT00608335 | Phase 1 | Completed |
| NCT00818584 | Phase 1 | Completed |
| NCT00842504 | Phase 1 | Completed |
Competing Products
20 competing products in Invasive Fungal Infections